Nagendra B Gutti

Dr. Nagendra B Gutti

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RMRoopali Mahajan
Roopali Mahajan
JKJayantee Kalita
Jayantee Kalita
VJVishal Jha
Vishal Jha
NGNagendra B Gutti
Nagendra B Gutti
PPPrakash Chandra Pandey
Prakash Chandra Pandey
UMUsha K. Misra
Usha K. Misra
Background: There is paucity of studies on the temporal pattern of recovery of facial, bulbar, sensory, motor, and autonomic dysfunction in Guillain–Barré syndrome (GBS), although many studies have reported short- and long-term functional outcomes. We report the temporal pattern of recovery of various neurological functions in GBS, and compare the pattern of recovery between acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). Methods: Forty-two patients with GBS were prospectively included, and their clinical details, including peak disability on a 0–6 scale, were noted. The day of complete recovery in motor, sensory, facial, bulbar, and autonomic functions during 3 months of follow-up was recorded. Results: Complete recovery of autonomic function occurred in all (median, 12 days), bulbar weakness in 91.3% (median, 15 days), facial weakness in 86.2% (median, 19 days), and sensory functions in 82.1% (median, 20 days). Only 9.5% of patients achieved normal motor function within 3 months. The days of complete recovery of bulbar, facial, autonomic, and motor deficits were comparable between AIDP and AMAN. Demyelinating GBS had an earlier recovery of bulbar and sensory functions. Conclusions: The neurological recovery in GBS occurs first in the autonomic, followed by the bulbar, facial, sensory, and motor functions. The demyelinating type had an earlier recovery of bulbar and sensory functions.

10 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JKJayantee Kalita
Jayantee Kalita
NGNagendra B Gutti
Nagendra B Gutti
PPPrakash Chandra Pandey
Prakash Chandra Pandey
KDKuntal K Das
Kuntal K Das
SKSunil Kumar
Sunil Kumar
VSVarun Kumar Singh
Varun Kumar Singh
Background: The patients with cerebral venous thrombosis (CVT) having raised intracranial pressure and seizures require admission to the intensive care unit (ICU). We report the outcomes of ICU admitted CVT patients, and compare the in-hospital death and 3-months disability between mechanically ventilated (MV) and non-MV groups. Methods: Forty-five CVT patients admitted to ICU were included. Their clinical details, MRI and MRV findings were noted. The patients were intubated based on arterial blood gas analysis. All the patients received heparin followed by an oral anticoagulant. In-hospital death and functional outcomes at 3 months were recorded. Results: 18/45 (40%) CVT patients required MV for a median of 6.5 (1-15) days. 9(20%) patients died; MV group had an insignificantly higher deaths compared to non-MV group [2(27%) vs 4(14.8%); P=0.45]. On Cox regression analysis, the GCS score independently predicted death (adjusted hazard ratio 0.75; 95% CI 0.59-.0.96; P=0.02) but not MV (HR 1.78; 95%CI0.47-6.77; P=0.39). Amongst the survivors, 30(85.7%) had a good outcome which was comparable between the two groups. Conclusion: 40% of CVT patients in ICU require MV. The overall mortality is 20%, and 85.7% of patients have a good outcome at 3 months, which is comparable between MV and non-MV groups.

12 November 2024 in Neurology
Verified
Journal Article
Closed access
NGNagendra B Gutti
Nagendra B Gutti
JKJayantee Kalita
Jayantee Kalita
DKDhiraj Kumar
Dhiraj Kumar
KDKuntal K. Das
Kuntal K. Das
ZNZafar Neyaz
Zafar Neyaz
We report a case of 32-year-old man with progressive, asymmetric, proximal weakness of both upper limbs for 14 months. On examination, he had gynecomastia and wasting and weakness of his deltoid, supraspinatus, infraspinatus, pectoralis, biceps, and triceps muscles, along with sensory loss of his left C5-C8 dermatomes. Deep tendon reflexes were depressed in the upper limbs and normal in the lower limbs. There was a history of a road traffic accident 2 years ago without any neurologic deficits. We discuss the clinical approach, differential diagnosis, investigations, and treatment options for bibrachial weakness.

24 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JKJayantee Kalita
Jayantee Kalita
PPPrakash Chandra Pandey
Prakash Chandra Pandey
NGNagendra B Gutti
Nagendra B Gutti
KDKuntal K. Das
Kuntal K. Das
SKSunil Kumar
Sunil Kumar
VSVarun K. Singh
Varun K. Singh
Background: Patients with cerebral venous thrombosis (CVT) requiring mechanical ventilation (MV) may have a severe procoagulant state, extensive venous sinus thrombosis, and a worse outcome, but there is a paucity of studies on this topic. We compare the clinical risk factors, radiological findings, and outcomes between CVT patients requiring MV and the non-MV group. Methods: Consecutive CVT patients admitted to our service were included. Their clinical details, prothrombotic states and MRI and MRV findings were noted. The patients were admitted to the intensive care unit (ICU) if the Glasgow Coma Scale (GCS) score was below 14 and intubated if arterial blood gas analysis was abnormal. All the patients received heparin followed by an oral anticoagulant. In-hospital death was noted, and functional outcomes at 3 months were assessed using the modified Rankin Scale (mRS). Results: Ninety-eight patients with CVT were admitted during the study period; 45 (45.9%) required ICU care, and 18 of them required MV for a median of 6.5 (1–15) days. The MV patients had a shorter duration of illness, a lower GCS score, and protein C deficiency. Twelve (12.2%) patients died: five (27.8%) in the MV, four (14.8%) in the non-MV ICU, and three (5.7%) in the non-MV non-ICU groups. Poor outcomes were 5.5%, 14.8%, and 5.7%, respectively. On Cox regression analysis, the MV had an association with death [adjusted hazard ratio (AHR) 0.40, 95% confidence interval 0.21–0.77; p = 0.007] and poor outcome at 3 months (AHR 0.45, 95% CI 0.27–0.76; p = 0.003). Conclusions: About 18.4% of CVT patients require MV with a mortality of 27.8%. Amongst the survivors, 90.7% of patients have a good outcome at 3 months.